1. Aebi, H., and Wartburg, J. P., 1960, Vergleichend-biologische Aspekte der experimentellen Erforschung chronischer Alkoholwirkungen, Bull. Schweiz. Akad. Med Wiss. 16:25.
2. Albertini, A., and Bonera, E., 1972, L’alcool-deidrogenasi epatica umana: Eterogenicità, regolazione e significato clinico delie variazioni dell’ attività enzimatica, Quad. Sclavo Diagn. Clin. Lab. 8:229.
3. Albertini, A., Bonera, E., Bordoni, L., and Galante, T., 1967, Comportamento di alcuni enzimi epatici e serici negli etilisti chronici, Ist. Lomb. Accad. sci. Lett., Rend. sci. Biol. Med. B-101:329.
4. Alpers, H. S., McLaughlin, B. R., Mix, W. M., Davis, V. E., 1975, Inhibition of catecholamine uptake and retention in synaptosomal preparations by tetrahydroiso-quinoline and tetrahydroprotoberberine alkaloids, Biochem. Pharmacol. 24:1391–96.
5. Azevedo, I., and Osswald, W., 1977, Adrenergic nerve degeneration induced by condensation products of adrenaline and acetaldehyde, Naunyn-Schmiedeberg’s Arch. Pharmacol. 300:139–44.